Associate
Sara has developed global prosecution strategies and prosecuted patent applications in fields spanning the life sciences, including antibodies, complement inhibition, controlled-release formulations, diagnostics and in vitro detection assays, dietary supplements, gene editing (e.g., CRISPR), gene therapy, immunology, immuno-oncology, metabolic disease, modified polynucleotides, neuroscience, nucleotide sequencing, protein purification, recombinant and fusion protein therapeutics, and vaccines.
Sara's technical expertise is in microbiology, bacterial genetics, and molecular biology. Her graduate thesis focused on the genetics and regulation of complex communities of bacteria known as biofilms.
Event
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Event
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology Patent Law
April 27, 2023
Cambridge
Prosecution First Blog
ChromaDex Fails to Milk Its Patent for Subject Matter Eligibility ChromaDex Fails to Milk Its Patent for Subject Matter Eligibility
March 17, 2023
Announcement
Finnegan Announces 2021 Mentors of the Year Finnegan Announces 2021 Mentors of the Year
December 28, 2021
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.